SCOTUS Urged to Review Merck Case Over Failure-to-Warn Claims

The Trump administration is urging the Supreme Court to take up a case testing whether the FDA’s refusal to approve a warning label on drugs preempts state laws that may require such labels.
Source: Drug GMP Report